Drugs and Biological Products With Average Total Allowed Charges Below the Applicable Threshold Pursuant to section 1847A(i)(2) of the Act, drugs and biological products, for which the average total allowed charges for such drug or biological under Part B for a year per individual who uses such drug or biological are below the applicable threshold, as determined by the Secretary, are excluded from the definition of Part B rebatable drugs
However, thats where the similarities end
As used in this subpart, the following definitions apply: 340B Program is the program under section 340B of the PHS Act
therefore, the care plan document should be updated at regularly defined intervals by the care team and patient
(5) Notwithstanding paragraph (e)(4) of this section, for a Part B rebatable drug that is a selected drug (as defined in section 1192(c) of the Act) with respect to a price applicability period (as defined in section 1191(b)(2) of the Act), in the case such Part B rebatable drug is no longer considered to be a selected drug, the benchmark period CPI-U is the CPI-U for the July of the year preceding the last year during such price applicability period
